Status:
COMPLETED
Pediatric Acute Respiratory Distress Syndrome Asia Study
Lead Sponsor:
KK Women's and Children's Hospital
Collaborating Sponsors:
Children's Hospital of Chongqing Medical University
Guangzhou Women and Children's Medical Center
Conditions:
Acute Respiratory Distress Syndrome
Pediatric Intensive Care Unit
Eligibility:
All Genders
Up to 21 years
Brief Summary
Mortality rates in children with pediatric acute respiratory distress syndrome (PARDS) are higher in Asia compared to other regions. In adults with acute respiratory distress syndrome, the only therap...
Detailed Description
The overall objective of this study is to prospectively determine the epidemiology of children with PARDS and describe its management in Asia. The first specific aim is to determine the prevalence of ...
Eligibility Criteria
Inclusion
- Satisfies the Pediatric Acute Lung Injury Consensus Conference (PALICC) criteria for PARDS
Exclusion
- Premature neonates with a corrected age of less than 33 weeks and perinatal lung disease
- High flow nasal cannula
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 7 2024
Estimated Enrollment :
738 Patients enrolled
Trial Details
Trial ID
NCT04068038
Start Date
August 1 2019
End Date
July 7 2024
Last Update
August 9 2024
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou Women and Children's Medical Center
Guangzhou, Guangzhou, China
2
Shengjing hospital of China Medical University
Shenyang, Liaoning, China
3
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China
4
Chongqing Hospital
Chongqing, Sichuan, China